ERBB2 and neoplasm: Additionally, immunofluorescence analysis on tumor sections using anti‐Ki67 antibody revealed that ebselen oxide was associated with a 32% drop of HER2+ breast tumor proliferation index compared with vehicle‐treated mice (Fig. 5L,M).